Giovanni Blandino
Overview
Explore the profile of Giovanni Blandino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
6956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Pascale V, Ganci F, Leone F, Manciocco V, Campo F, Mercurio A, et al.
Precis Clin Med
. 2025 Mar;
8(1):pbaf005.
PMID: 40083592
No abstract available.
2.
Scafetta G, Rampioni Vinciguerra G, Giglio S, Faruq O, Cirombella R, Segatto I, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):96.
PMID: 40082972
Breast cancer ranks as the most prevalent form of cancer globally. Currently, advanced screening methods have significantly improved early detection rates. These achievements have led to more non-invasive cancer diagnoses...
3.
Galati L, Tagliabue M, Gheit T, De Berardinis R, Maffini F, McKay-Chopin S, et al.
J Med Virol
. 2025 Mar;
97(3):e70278.
PMID: 40052199
Oral HPV DNA and circulating tumor (ct) HPV DNA in plasma were evaluated as potential biomarkers for HPV-associated head and neck cancer (HNC). Samples from HNC patients (n = 132),...
4.
Campo F, Paolini F, Terrenato I, Blandino G, De Pascale V, Locca O, et al.
Eur Arch Otorhinolaryngol
. 2025 Jan;
PMID: 39863814
Objectives: we evaluated the hypothesis that level of ctHPVDNA on the first postoperative day (POD-1); and at 15 days (POD-15) could be associated with the need for adjuvant therapy and...
5.
Blandino G, Satchi-Fainaro R, Tinhofer I, Tonon G, Heilshorn S, Kwon Y, et al.
J Exp Clin Cancer Res
. 2024 Dec;
43(1):334.
PMID: 39731178
On September 23-24 (2024) the 6th Workshop IRE on Translational Oncology, titled "Cancer Organoids as Reliable Disease Models to Drive Clinical Development of Novel Therapies," took place at the IRCCS...
6.
Bruno T, Catena V, Blandino G, Fanciulli M, Di Agostino S
J Exp Clin Cancer Res
. 2024 Dec;
43(1):322.
PMID: 39695699
Multiple myeloma (MM), a hematologic malignancy characterized by the clonal expansion of plasma cells within the bone marrow, is associated with severe health complications, including osteolytic bone lesions that significantly...
7.
Sanghvi N, Calvo-Alcaniz C, Rajagopal P, Scalera S, Canu V, Sinha S, et al.
Sci Adv
. 2024 Dec;
10(49):eadn0220.
PMID: 39642223
Metastasis is a leading cause of cancer-related deaths, yet understanding how metastatic tumors adapt from their origin to their target tissues remains a fundamental challenge. To address this, we assessed...
8.
Lo Sardo F, Turco C, Messina B, Sacconi A, Auciello F, Pulito C, et al.
Cell Death Discov
. 2024 Oct;
10(1):452.
PMID: 39455556
The tumor suppressor PTEN (phosphatase and tensin homolog deleted in chromosome 10) is genetically deleted or downregulated in many cancer types. Loss of PTEN protein expression is frequently found in...
9.
Piastra V, Ganci F, Sacconi A, Pranteda A, Allegretti M, Bernardini R, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):234.
PMID: 39164711
Background: Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer-related deaths worldwide, with a survival rate near to 10% when diagnosed...
10.
Canu V, Vaccarella S, Sacconi A, Pulito C, Goeman F, Pallocca M, et al.
Cell Death Dis
. 2024 Aug;
15(8):603.
PMID: 39164278
Triple negative breast cancer (TNBC) is an aggressive disease which currently has no effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 (SPAG5) is a mitotic spindle associated...